Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol
2. El 737
3. El-737
4. Ly 031537
5. Ly-031537
6. Ractopamine
1. 90274-24-1
2. Ractopamine Hcl
3. 4-(1-hydroxy-2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)phenol Hydrochloride
4. El737
5. Lyo31537
6. Nsc-759638
7. Ractopamine (hydrochloride)
8. 4-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]butyl]phenol;hydrochloride
9. 309g9j93tp
10. Lyo-31537
11. El-737
12. Topmax
13. El 737; Ly 031537; Ly O31537; Optaflexx; Paylean;topmax 9
14. Paylean 9
15. Optaflexx 45
16. Ractopaminehydrochloride
17. Ncgc00164602-01
18. Unii-309g9j93tp
19. Ractopamine Hydrochloride [usan]
20. Ractopamine-d6 Hcl
21. Ractopamine Hydrochloride [usan:usp]
22. Ractopamine Hcl - 95%
23. Ec 415-170-5
24. Dsstox_cid_26471
25. Dsstox_rid_81643
26. Dsstox_gsid_46471
27. Benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, Hydrochloride
28. Schembl350754
29. Chembl2105358
30. Dtxsid1046471
31. Ractopamine Hydrochloride (usp)
32. Pharmakon1600-01502332
33. Tox21_112224
34. Mfcd07781271
35. Nsc759638
36. Ractopamine Hydrochloride [mi]
37. 4-{3-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]aminobutylphenol Hydrochloride
38. Akos015961286
39. At25794
40. Ccg-213033
41. Nsc 759638
42. As-13956
43. Br162257
44. Br164308
45. Ractopamine Hydrochloride [usp-rs]
46. Cas-90274-24-1
47. Db-057193
48. Ft-0630973
49. Ft-0663927
50. Sw220070-1
51. Ractopamine Hydrochloride [green Book]
52. D05691
53. Ractopamine Hydrochloride [usp Impurity]
54. 274r241
55. Ractopamine Hydrochloride 100 Microg/ml In Ethanol
56. Ractopamine Hydrochloride 1000 Microg/ml In Ethanol
57. Q27255947
58. Ractopamine Hydrochloride 1000 Microg/ml In Methanol
59. Rac Ractopamine Hydrochloride (mixture Of Diastereomers)
60. Ractopamine Hydrochloride, Vetranal(tm), Analytical Standard
61. 4-hydroxy-?-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]phenol Hydrochloride
62. Ractopamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
63. (+-)-all-rac-p-hydroxy-alpha-(((3-(p-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzyl Alcohol, Hydrochloride
64. (+/-)-4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)-1-hydroxyethyl)phenol Hydrochloride
65. (+/-)-all-rac-p-hydroxy-.alpha.-(((3-(p-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzyl Alcohol, Hydrochloride
66. Benzenemethanol, 4-hydroxy-.alpha.-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, Hydrochloride
67. Ractopamine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 337.8 g/mol |
|---|---|
| Molecular Formula | C18H24ClNO3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 337.1444713 g/mol |
| Monoisotopic Mass | 337.1444713 g/mol |
| Topological Polar Surface Area | 72.7 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 297 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ractopamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ractopamine Hydrochloride, including repackagers and relabelers. The FDA regulates Ractopamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ractopamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ractopamine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ractopamine Hydrochloride supplier is an individual or a company that provides Ractopamine Hydrochloride active pharmaceutical ingredient (API) or Ractopamine Hydrochloride finished formulations upon request. The Ractopamine Hydrochloride suppliers may include Ractopamine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ractopamine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ractopamine Hydrochloride written confirmation (Ractopamine Hydrochloride WC) is an official document issued by a regulatory agency to a Ractopamine Hydrochloride manufacturer, verifying that the manufacturing facility of a Ractopamine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ractopamine Hydrochloride APIs or Ractopamine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ractopamine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ractopamine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ractopamine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ractopamine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ractopamine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ractopamine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ractopamine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ractopamine Hydrochloride suppliers with NDC on PharmaCompass.
Ractopamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ractopamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ractopamine Hydrochloride GMP manufacturer or Ractopamine Hydrochloride GMP API supplier for your needs.
A Ractopamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ractopamine Hydrochloride's compliance with Ractopamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Ractopamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ractopamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ractopamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ractopamine Hydrochloride EP), Ractopamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ractopamine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
